Introduction: Leiomyosarcoma of the venous system is rare, even more so in the greater saphenous vein. In the 85 years since van Ree described the first case in 1919 only 25 cases have been reported in the world. Methods: We describe a case of an 85-year-old woman who was successfully treated by excision of the tumour. We also reviewed pertinent literature with regard to age, gender spread, tumour size, survival, occurrence of metastases and therapy. Results: The median age was 54 years (range 2-85 years), with a 3:2 female to male ratio. The median size of the tumours was 4.1 cm (range 2-12 cm) and metastases occurred in seven of the 25 cases. If any form of adjuvant therapy is used it is usually radiotherapy. Chemotherapy seems to be reserved for cases where metastasis occurs. Average survival was 4 years (range 1 month to 17 years). Currently the best treatment seems to be wide excision of the tumour, with selective vascular reconstruction combined with adjuvant radiotherapy.
Introduction
Primary malignant venous tumours are very rare. Leiomyosarcoma of the saphenous vein even more so, constituting about one in every million malignant tumours. In the 85 years since Van Ree reported the first case in 1919, only 24 cases have been reported in the international literature. We describe an additional one, and pertinent literature is reviewed.
Case
An 85-year-old woman was admitted to our hospital with loss of weight and general discomfort. She also complained of a progressive and painful swelling in the right groin, which she had noticed 3 weeks before. She had no relevant medical history.
On physical examination the woman was seen to be cachectic. A solid swelling with a diameter of 3 cm was observed in the right groin inferior to the inguinal ligament. The swelling was mobile in relation to the skin but fixed to a deeper structure. It was thought to be an enlarged lymph node.
Further physical examination showed no other abnormalities.
Additional ultrasound and MRI of the right groin showed a tumour 2.5 cm in diameter in close proximity of the femoral vein (without obstructing it) and the cortex of the pubic bone just below the skin. Ultrasound guided biopsy showed leiomyosarcoma grade II. Preoperative workup showed no evidence of metastases.
During surgery we observed that the tumour originated from the great saphenous vein close to its insertion in the common femoral vein (Fig. 1) The tumour was excised with a wide margin.
Pathological examination of the excised tumour showed a leiomyosarcoma grade II with a diameter of 3.6 cm radically excised and four lympnodes with reactive changes but no signs of metastasis.
Postoperative course was complicated by a wound infection, which was contained with a wound debridement and antibiotics. There were no further complications and the patient made a slow but full recovery. After 27 days she was discharged from the hospital.
She refused adjuvant radiotherapy. At her last outpatient visit, 2 months after the surgery, the wound had fully healed, and she suffered no effects from surgery.
Discussion
Malignant tumours that arise from venous walls are very uncommon, even more so in the lower extremity. 1, 3 Primary venous leiomyosarcomas constitute less than one in every 100,000 malignant tumours, and about 10% of these originate from the great saphenous vein, with the inferior caval vein being the predominant location. This case is the second reported in the Dutch literature, and only the 25th in the international literature. The international literature consists mostly of case reports. There are only a few reviews and series.
Reix et al. 1 describe a series of seven patients with a venous tumour, six with a leimyosarcoma and one with hemangioendothelioma. Four of them originated from the superficial femoral vein, two from the common femoral vein and only one originated from the great saphenous vein. Median survival in this group was 31 months. Most of them died from metastasis. Local recurrence was never observed.
Of the patients with leiomyosarcoma, four received adjuvant radiotherapy (60 Gy in all cases), one refused; and in one case was not indicated because the tumour was small and wide, and wide excision was performed. Chemotherapy was only offered in case of metastasis. Prognosis was poor due to early occurrence of metastasis, occurring in six of the seven cases.
In the same institute, a study was conducted to assess the best imaging technique for diagnosing venous tumours. It was concluded that echo duplex and MRI were best suited for diagnosis of venous tumours. 2 This was confirmed by Dzsinich et al.
3
The latter author described a series of 13 patients with a primary venous leiomyosarcoma. 3 Of these 13, only two had a tumour arising from the greater saphenous vein. Most occurred in the inferior caval vein. At the time of their publication they state that only 197 cases of primary venous leiomyosarcoma had been reported in the period of over 100 years since Perl 4 reported the first in 1871. Of these, only 19 originated from the greater saphenous vein.
Humphrey et al. 5 described a case and reviewed the literature. At the time of their publication in 1987, only 15 cases of a leiomyosarcoma originating from the great saphenous vein had been reported, In previous reports describing leiomyosarcomas of the venous system in the lower extremities 1, 5 no gender predisposition was observed, which was somewhat surprising taking into account that a 4:1 female to male ratio is observed when the leimyosarcoma is located in the inferior caval vein. With 25 cases reviewed we observe a 3:2 female to male ratio.
The median size of the tumours was 4.1 cm, with a range from 2 to 12 cm. This is much smaller compared with leiomyosarcoma of the inferior caval vein, with a median size greater than 10 cm. 3 Metastases occurred in seven of the 25 cases, with the lungs being the predominant site, and were the main cause of death. Because leiomyosarcomas are slow-growing tumours they often stay undetected for a long time, which is probably one of the causes of the large proportion of patients with metastases.
If any form of adjuvant therapy is given it is usually radiotherapy. The level of evidence to support this is low because of the rarity of the disease. However Mutter et al. 13 state that radiotherapy, 55-70 Gy, should follow excision of primary leiomyosarcoma if it occurs in the femoral vein. We offered it to our patient but she refused to undergo radiotherapy. Chemotherapy is mostly reserved to treat metastasis, with a wide variety of regimes being used, but doxorubicin and methotrexate are most commonly used. Initially the metastases respond well to the therapy, but ultimately the patient dies. 1, 9 When reviewing the literature, survival is found to be limited, with median survival ranging from 2.5 to about 4 years. 1, 3, 5 With 25 cases reviewed we find an average survival of 4 years, which could be much better if corrected for the short follow-up periods in some reports. The longest disease-free survival reported is 17 years. 5 In conclusion, it can be stated that leiomyosarcoma of the saphenous vein is a very rare tumour. Because of its location in a vein, and because of its slow-growing tendency, and therefore its high rate of metastasis, survival is limited. If metastases occur, the lungs are the predominant site. In terms of diagnosis, MRI and Doppler echography seem to be the imaging techniques of choice. Because of the rarity of the disease there can be no conclusions drawn with regard to the necessity of adjuvant therapy. Radiotherapy is, however, frequently offered and seems beneficial.
Wide local excision with selective venous reconstruction, and adjuvant local radiotherapy, probably offers the only hope for prolonged survival.
